Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group

MLA

Hong-Suk Song, et al. “Multicenter Phase II Study of Docetaxel plus Oxaliplatin Combination Chemotherapy in Patients with Advanced Gastric Cancer: Daegu Gyeongbuk Oncology Group.” British Journal of Cancer, vol. 98, Jan. 2008, pp. 542–46. EBSCOhost, https://doi.org/10.1038/sj.bjc.6604188.

APA

Hong-Suk Song, Sung Hwa Bae, Ryoo Hm, Kim Mk, K. H. Lee, Lee Ws, Kwon Ky, Ho Young Chung, S K Sohn, Do Yr, Yee Soo Chae, Jong Gwang Kim, Wansik Yu, Baek Jh, Hyun Ms, & Park Ku. (2008). Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group. British Journal of Cancer, 98, 542–546. https://doi.org/10.1038/sj.bjc.6604188

Chicago

Hong-Suk Song, Sung Hwa Bae, Ryoo Hm, Kim Mk, K. H. Lee, Lee Ws, Kwon Ky, et al. 2008. “Multicenter Phase II Study of Docetaxel plus Oxaliplatin Combination Chemotherapy in Patients with Advanced Gastric Cancer: Daegu Gyeongbuk Oncology Group.” British Journal of Cancer 98 (January): 542–46. doi:10.1038/sj.bjc.6604188.